| scholarly article | Q13442814 |
| P50 | author | Gerard Pasterkamp | Q57298458 |
| P2093 | author name string | Laman JD | |
| de Kleijn DP | |||
| Schoneveld AH | |||
| Oude Nijhuis MM | |||
| van Middelaar B | |||
| P2860 | cites work | T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. | Q51835996 |
| P433 | issue | 1 | |
| P921 | main subject | toll-like receptor | Q408004 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 162-169 | |
| P577 | publication date | 2005-01-13 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development | |
| P478 | volume | 66 |
| Q37765286 | Biomarkers of vulnerable plaque: the missing link with ischemia. |
| Q37729330 | Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice |
| Q37860795 | Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. |
| Q37580244 | Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice |
| Q26852204 | Danger signaling in atherosclerosis |
| Q33918139 | Enhanced neointima formation following arterial injury in immune deficient Rag-1-/- mice is attenuated by adoptive transfer of CD8 T cells |
| Q36158656 | Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the Atherosclerosis Risk in Communities MRI Study |
| Q42144631 | Genomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathway |
| Q52883205 | Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophages. |
| Q37848659 | Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae |
| Q98226408 | Innate Immune Receptors, Key Actors in Cardiovascular Diseases |
| Q37859249 | Innate immune signaling in cardiac ischemia |
| Q34980214 | Innate immunity and monocyte-macrophage activation in atherosclerosis. |
| Q46933998 | Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells |
| Q28576281 | LPS from Porphyromonas gingivalis increases the sensitivity of contractile response mediated by endothelin-B (ET(B)) receptors in cultured endothelium-intact rat coronary arteries |
| Q40090464 | LincRNA DYN-LRB2-2 upregulates cholesterol efflux by decreasing TLR2 expression in macrophages |
| Q42833865 | Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes |
| Q36891895 | Mechanisms of disease: Toll-like receptors in cardiovascular disease |
| Q39418237 | Mechanisms of erosion of atherosclerotic plaques. |
| Q36012953 | Metabolic syndrome: the danger signal in atherosclerosis |
| Q34063165 | Modulation of atherosclerosis in mice by Toll-like receptor 2 |
| Q38125279 | Molecular biology of atherosclerosis |
| Q36722515 | Oxidised phospholipid regulation of Toll-like receptor signalling. |
| Q41862930 | Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. |
| Q40163261 | Peptidoglycan increases firm adhesion of monocytes under flow conditions and primes monocyte chemotaxis |
| Q90288795 | Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles |
| Q44255321 | Porphyromonas gingivalis promotes neointimal formation after arterial injury through toll-like receptor 2 signaling |
| Q37295072 | Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells |
| Q58702074 | RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy |
| Q26823875 | Role of vascular smooth muscle cell in the inflammation of atherosclerosis |
| Q39992138 | Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate. |
| Q27301022 | Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury |
| Q28077737 | The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis |
| Q36055619 | The adventitia: a dynamic interface containing resident progenitor cells. |
| Q39654626 | The capacity of foodstuffs to induce innate immune activation of human monocytesin vitrois dependent on food content of stimulants of Toll-like receptors 2 and 4 |
| Q37977824 | The innate immune response in reperfused myocardium |
| Q35613022 | The putative tumor suppressor Zc3h12d modulates toll-like receptor signaling in macrophages |
| Q39459619 | The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques |
| Q29248835 | Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions |
| Q49629969 | Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor-κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis |
| Q53640794 | Toll-like receptor 2 mediates vascular contraction and activates RhoA signaling in vascular smooth muscle cells from STZ-induced type 1 diabetic rats. |
| Q37859678 | Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis |
| Q27300289 | Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings |
| Q36557759 | Toll-like receptors and atherosclerosis: key contributors in disease and health? |
| Q37198685 | Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness? |
| Q37352820 | Toll-like receptors, wound healing, and carcinogenesis |
| Q37421811 | Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease |
| Q37810915 | Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets |
| Q36716427 | Update on advances in atherothrombosis |
| Q38353932 | Vascular smooth muscle cell in atherosclerosis |
| Q34782535 | Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series). |
| Q35068901 | Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions |
Search more.